Guangji Pharmaceutical: Announcement of Board Resolutions in Semi-annual Report
Securities code: 000952 Securities abbreviation: Guangji Pharmaceutical Announcement number: 2025-043 Hubei Guangji Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 10th Meeting of the 11th Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Convening of board of directors meetings
Time and method of meeting notice: The meeting notice will be sent by personal delivery, written fax and email on August 15, 2025;
Time and method of the meeting: It will be held at 10 a.m. on August 27, 2025 in the conference room on the second floor of the administrative building of Dajin Industrial Park, Wuxue City, Hubei Guangji Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") through on-site communication and communication;
9 directors (including 3 independent directors) should be present at this meeting, and 9 directors actually attended. Mr. Hu Ligang, Mr. Gong Cheng, Mr. Guo Shaozhi, and Mr. Fang Zhi voted on site, and Mr. Liu Bo, Mr. Shi Shoudong, Mr. Guo Wei, Ms. Hong Kui, and Mr. Mei Jianming voted by communication;
This meeting was chaired by Chairman Mr. Hu Ligang, and all supervisors and senior managers attended the meeting;
The convening of this meeting complied with the relevant provisions of the "Company Law of the People's Republic of China" and the "Articles of Association", and the resolutions of the meeting were legal and valid.
2. Review status of board of directors meeting
(1) Consideration and approval of the "2025 Semi-Annual Report" and "2025 Semi-Annual Report Summary"
The board of directors reviewed and approved the "2025 Semi-Annual Report" and the "2025 Semi-Annual Report Summary". The board of directors believes that the semi-annual report and its summary truly reflect the company's financial status and operating results for the first half of 2025, and there are no false records, misleading statements or major omissions.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved by the Fifth Audit Committee of the 11th Board of Directors of the Company, and it was agreed to submit the proposal to this Board of Directors for review.
For details, please refer to the "2025 Semi-Annual Report" and "2025 Semi-Annual Report Summary" disclosed by the company on the designated media on the same day (Announcement No.: 2025-045).
(2) Consider and approve the "Proposal on Changing Registered Capital and Amending the Articles of Association"
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be submitted to the company's shareholders' meeting for review.
For details, please refer to the "Announcement on Change of Registered Capital and Revision of the Articles of Association" (Announcement No.: 2025-046) and "Articles of Association of Hubei Guangji Pharmaceutical Co., Ltd. (Proposed Revised Draft)" disclosed by the company on the designated media on the same day.
(3) Consideration and approval of the "Proposal on Amending the Rules of Procedure of the Shareholders' Meeting"
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be submitted to the company's shareholders' meeting for review.
For details, please refer to the “Rules of Procedure for the Shareholders’ Meeting of Hubei Guangji Pharmaceutical Co., Ltd.” (to be revised) and the “Revision Comparison Table of the Rules of Procedure for the Shareholders’ Meeting of Hubei Guangji Pharmaceutical Co., Ltd.” disclosed by the company on the designated media on the same day.
(4) Consideration and approval of the “Proposal on Amending the Rules of Procedure of the Board of Directors”
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be submitted to the company's shareholders' meeting for review.
For details, please refer to the "Rules of Procedures of the Board of Directors of Hubei Guangji Pharmaceutical Co., Ltd." (to be revised) and the "Revision Comparison Table of Rules of Procedures of the Board of Directors of Hubei Guangji Pharmaceutical Co., Ltd." disclosed by the company on the designated media on the same day.
(5) Consideration and approval of the “Proposal on Convening the Third Extraordinary Shareholders’ Meeting in 2025”
The company plans to hold the third extraordinary shareholders' meeting of Hubei Guangji Pharmaceutical Co., Ltd. in 2025 at 3:30 pm on September 18, 2025 (Thursday) in the conference room on the second floor of the Administrative Building, Daijin Industrial Park, No. 100, Meiwu Road, Dajin Town, Wuxue City, Hubei Province.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
For details, please refer to the "Notice on Convening the Third Extraordinary Shareholders Meeting in 2025" disclosed by the company on the designated media on the same day (announcement number: 2025-047).
3. Documents for reference
Resolution of the 10th meeting of the 11th Board of Directors of the company signed by the attending directors and stamped with the seal of the Board of Directors.
Announcement is hereby made.
Board of Directors of Hubei Guangji Pharmaceutical Co., Ltd.
August 27, 2025